Cardioplegic solution

Details Cardioplegic solution Cardioplegic solution

2007-09-18

2007-09-18

Naff, David M. (Department: 1651)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

C424S610000, C424S686000, C424S715000

Reexamination Certificate

active

10344038

ABSTRACT:
Use of potassium for the production of a cardioplegic solution for the prevention of stone heart development during acute cardiac ventricular fibrillation in connection with cardiopulmonary resuscitation is described, as well as a cardioplegic solution comprising potassium and a method for the prevention of stone heart developement during acute cardiac ventricular fibrillation in connection with cardiopulmonary resuscitation.

REFERENCES:
patent: 5552267 (1996-09-01), Stern et al.
patent: 6449507 (2002-09-01), Hill et al.
patent: 1176651 (1964-08-01), None
“Conversion of Postischemic Ventricular Fibrilation With Intraaortic Infusion of Potassium Chloride,” Eivind Ovrum et al, Ann Thorac Surg, vol. 60, No. 1, 1995.
19thCongress of the Scandinavian Society of Anaesthesiologists in Linkoping, Ssweden, Jun. 29-Jul. 3, 1987, “Acta Anaesthesiologica Scandinavia,” Supplementum 86, vol. 31, 1987, L. Bjella et al, “Potassium Chloride Used to Prevent Ventricular Fibrillation at Reperfusion in Open Heart Surgery,” No. 11.
Heart, vol. 80, No. 4, 1998, D.A. Chamberlain, “Antiarrhythmic Drugs in Resuscitation”.
The Canadian Journal of Surgery, vol. 23, No. 2, Mar. 1980, A. Addetia et al, “Perfusion in Cardioplegia: an Experimental Study”.
Anaesthesiol Reanimat, vol. 18, No. 6, 1993, Von H. Wulf et al, “Kaliumsubstitution bei koronarchirgischen Eingriffen: K+-Mg++-Aspartat-Komplex (Inzolen) versus Kaliumchlotid,”.
The American Journal of Cardiology, vol. 33, No. 1, Jan. 1974, John C Fischer et al, “Studies on Ventricular Defibrillation”.
File WPI, Derwent Accession No. 1996-096008, Novos Blood Circulation Pathology Inst, “Protecting Myocardium in Heart Operation-with Perfusion-free Hypothermia by Introduction of Cooled Cardioplegic Soln.Contg. Potassium”.
File WPI, Derwent Accession No. 2000-557077, Blood Circulation Pathology Res Inst, “Method of Prophylaxis Heart Rhythm Disorder in Cardiosurgery Operations”.
Susan Budavari et al, “The Merck Index, eleventh edition,” 1989, Merk & Co., Inc., p. 1211-1213, No. 7580, 7586, 7599, 7601; p. 1216, No. 7647.

Affiliated with

Also associated with

Rating

Cardioplegic solution does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cardioplegic solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardioplegic solution will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3734799